Woman’s Inoperable Brain Tumor Shrinks In Just Five Days Thanks To Cancer Breakthrough

In March 2024, physicians at Mass General Brigham attempted an ambitious variation of CAR-T therapy on three patients battling recurrent glioblastoma, among the most lethal brain cancers known to medicine.

Rather than following standard protocols, they enhanced an existing CAR-T approach with targeted antibodies. This combination effectively sharpened continue reading …